fashion -WSS

fashion

author：comprehensive 2025-08-11 09:49:46 - browse：22789

A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT — Adobe

The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Cassava Sciences’ Alzheimer’s clinical trials should be halted

Wikipedia

WSS

ADCs take center stage as promising cancer treatments

STAT Summit: Ending the crisis of Black deaths in the U.S.

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

What is STAT's opinion section for?

White House drug czar issues call for 'recovery

Wikipedia

fashion

hotspot

Supreme Court strikes down use of affirmative action

Carbon Health diabetes program, a test of data

Walensky prepares to leave CDC — and Congress — behind

The problems with dementia villages

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Weight loss drugs should be covered by insurers, AMA says

Novavax promises a turnaround & Lilly roils the obesity market

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Novavax promises a turnaround & Lilly roils the obesity market

NIH chief: government has fallen behind pharma on clinical trials

entertainment

Ohio still needs to do more to protect the right to abortion

Cassava Sciences’ Alzheimer’s clinical trials should be halted

FDA clears Verve to begin U.S. study of gene

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Health tech investors get more selective as pandemic boom fades

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Wikipedia

explore

Wikipedia

entertainment